Pillar Marketing Group, Inc., Announces Acquisition Purchase of Controlling interest in Select-TV Solutions, Inc., Changing their name to BioQuest Corp. and Appoints Thomas Hemingway as Chairman and CEO.
November 18, 2019 08:15 ET
|
BioQuest Corp
Newport Beach, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioQuest Corp, (BQST or the “COMPANY”) (OTC:BQST), (the temporary symbol on 11/15/2019 is SELTD. Please note that a “D” has been appended as the...
H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD
November 18, 2019 08:00 ET
|
H-CYTE, Inc.
TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
BioSig Technologies Welcomes the Creation of New Bioelectronic Medicine Alliance
November 18, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 18, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
BIOMEDevice San Jose Announces 2019 Content to Support Digital Health Innovation Enhancing the Patient Experience
November 14, 2019 11:02 ET
|
BioMEDDevice / ESC San Jose
SANTA MONICA, Calif., Nov. 14, 2019 (GLOBE NEWSWIRE) -- BIOMEDevice San Jose, Silicon Valley’s leading event for medtech professionals, today announced its 2019 show focus on digital health...
BioSig Technologies Issues November 2019 Shareholder Letter
November 14, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 14, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal...
NewLink Genetics Announces European Commission Grant of Conditional Marketing Approval for Ebola Vaccine V920 (ERVEBO®)
November 12, 2019 09:00 ET
|
NewLink Genetics Corporation
AMES, Iowa, Nov. 12, 2019 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) announced that Monday, November 11th, the European Commission (EC) granted a conditional marketing...
Myriad’s Prequel™ Prenatal Screen Demonstrates High Performance Across All Fetal-Fraction Levels in Women Undergoing Noninvasive Prenatal Screening
November 11, 2019 07:05 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 11, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced...
New Studies Demonstrate the Predictive Value of the Vectra® Test in People Diagnosed with Rheumatoid Arthritis
November 09, 2019 16:30 ET
|
Myriad Genetics, Inc.
SALT LAKE CITY, Nov. 09, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in precision medicine, announced that its Myriad Autoimmune business unit will present new...
BioSig Technologies Invests in Union College’s Internship Program
November 07, 2019 07:52 ET
|
BioSig Technologies, Inc.
Westport, CT, Nov. 07, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or “The Company”), a medical technology company developing a proprietary biomedical signal...
Emerald Health Therapeutics to Supply STENOCARE with Medical Cannabis Products for Denmark
November 07, 2019 07:00 ET
|
Emerald Health Therapeutics Inc.
VANCOUVER, British Columbia, Nov. 07, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has signed an agreement to become a new supplier to STENOCARE...